AC
ABUS icon

Armistice Capital’s Arbutus Biopharma ABUS Stock Holding History

Armistice Capital’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,600,000
Closed -$5.2M – 60
2017
Q1 		$5.2M Sell
1,600,000
-340,000
-18% -$943K 1.34% 34
2016
Q4 		$4.75M Buy
1,940,000
+540,000
+39% +$1.57M 1.35% 35
2016
Q3 		$4.82M Buy
1,400,000
+992,000
+243% +$3.88M 1.92% 27
2016
Q2 		$1.42M Buy
+408,000
New +$1.73M 0.67% 41

Other funds holding ABUS

QF
QVT Financial New York $1.27B AUM 148.1% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $245B AUM 31.4% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $947M AUM 29.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return